Shopping Cart

No products in the cart.
Toggle Side Panel

Shopping Cart

No products in the cart.
Close search

Latest at the Lab

HITLAB Launches New Weekly Tuesday Series Spotlighting Evidence-Based Health Innovation

READ MORE
Publications
Posters
All

Categories

Tags

Curio Study (wide)

Curio Digital Therapeutics: Pivotal Trial for Postpartum Depression Digital Therapeutic Meets Efficacy Endpoints

HITLAB Welcomes Laurent van Lerberghe as New Board Member of Breakthrough Alliance and Chairman of Board for Europe

How Start-up BirthVue Is Helping Moms During Labor and Delivery

Clinical Trials Designed for the Patient: How Remote Technologies Improve Engagement

BTA Fall 2023 Innovators Challenge

Applications Open for HITLAB Fall 2023 Breakthrough Alliance Challenge

white_paper_graphic_hi_res

White Paper: Validation of Babbly’s AI Algorithm for the Classification of Infant Language Milestones

HITLAB, Columbia University and Babbly announce the results of an external validation study

HelixVM™ teams up with HITLAB to enhance its medical marketplace, fortifying triage clearinghouse and fast-tracking patient care

roberto-sorin-RS0-h_pyByk-unsplash

FFF Enterprises: The Battle to Reign In the Opioid Crisis

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .